|
Volumn 25, Issue 7, 2015, Pages 1621-1626
|
Minimization of drug-drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators
b
WUXI APPTEC
(China)
|
Author keywords
Alzheimers disease; Amyloid beta; Cytochrome P450 3A4; Drugdrug interactions; Gamma secretase modulator; Natural product; Semisynthesis; Sterol
|
Indexed keywords
APPARENT LIFE THREATENING EVENT;
ARTICLE;
BLEEDING;
CATHETER COMPLICATION;
CATHETER DISLODGEMENT;
CATHETER INFECTION;
CATHETER MIGRATION;
CATHETER THROMBOSIS;
CENTRAL VENOUS CATHETER;
DEVICE SAFETY;
HUMAN;
SUTURE;
TECHNOLOGY;
THERAPY DELAY;
VASCULAR ACCESS;
VEIN INJURY;
VEIN THROMBOSIS;
ANIMAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
CONFORMATION;
DOSE RESPONSE;
METABOLISM;
RAT;
SPRAGUE DAWLEY RAT;
STRUCTURE ACTIVITY RELATION;
RATTUS;
AZETIDINE DERIVATIVE;
BIOLOGICAL PRODUCT;
CYP3A4 PROTEIN, HUMAN;
CYTOCHROME P450 3A;
SPI-1865;
STEROID;
ANIMALS;
AZETIDINES;
BIOLOGICAL PRODUCTS;
CYTOCHROME P-450 CYP3A;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
RATS;
RATS, SPRAGUE-DAWLEY;
STEROIDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84925057498
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2015.01.051 Document Type: Article |
Times cited : (8)
|
References (11)
|